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We report here the identification of a 24-kDa polypeptide in IBV-infected Vero cells by immunoprecipitation with a
region-specific antiserum raised in rabbits against the IBV sequence encoded between nucleotides 10928 and 11493.
Coexpression, deletion, and mutagenesis studies have demonstrated that this protein is encoded by ORF 1a from nucleotide
10915 to 11544 and is released from the 1a polyprotein by the 3C-like proteinase-mediated proteolysis. A previously
predicted Q-S (Q3462S3463) dipeptide bond encoded by the IBV sequence from nucleotide 10912 to 10917 is identified as the
N-terminal cleavage site, and a Q-N (Q3672N3673) dipeptide bond encoded by the IBV sequence between nucleotides 11542
and 11547 is identified as the C-terminal cleavage site of the 24-kDa polypeptide. © 1998 Academic Press
INTRODUCTION
The avian infectious bronchitis virus (IBV) is the prototype
species of the Coronaviridae, a family of enveloped viruses
with large positive-stranded RNA genomes. Six mRNA spe-
cies (mRNAs 1–6) are involved in the expression of IBV
genes. Among them, the 27.6-kb genome-length mRNA,
mRNA 1, is composed of two large overlapping ORFs (1a
and 1b) at the 59-unique region and has the capacity to
encode a fusion polyprotein of 741 kDa by a ribosomal
frameshifting mechanism (Boursnell et al., 1987; Brierley et
al., 1987, 1989). Proteolytic processing of the 441-kDa 1a
polyprotein and the 741-kDa 1a/1b fusion polyprotein to
smaller functional products is expected to be mediated by
viral proteinases. Three proteinase domains, namely, two
overlapping papain-like and a picornavirus 3C-like protein-
ase domains, have been predicted to be encoded by the
ORF 1a sequences from nucleotide 4243 to 5553 and from
8937 to 9357, respectively (Gorbalenya et al., 1989; Lee et
al., 1991).
Recently, considerable progress has been made in the
identification and characterization of the ORF1a-encoding
proteinase activities as well as their cleavage products. The
two overlapping papain-like proteinase domains and cellu-
lar proteinase(s) were demonstrated to be involved in pro-
cessing of the 1a polyprotein to an 87-kDa protein (Liu et al.,
1995). The 3C-like proteinase is responsible for processing
of the 1a and 1a/1b polyproteins to a 10- and a 100-kDa
protein (Liu et al., 1994, 1997; Liu and Brown, 1995). Proteo-
lytic processing of the 1a and 1a/1b polyproteins by the
equivalent proteinase activities of human coronavirus and
mouse hepatitis virus has also been documented. In the
case of human coronavirus, four mature products have
been identified so far. These include a 34-kDa protein
representing the 3C-like proteinase, a 105-kDa protein cor-
responding to the 100-kDa protein of IBV, a 71-kDa protein
with an ATPase activity and a 41-kDa protein processed
from the 1b polyprotein (Ziebuhr et al., 1995; Grotzinger et
al., 1996; Heusipp et al., 1997a,b). Similarly, three mature
products, including two N-terminal cleavage products of 28
and 65 kDa and a 27-kDa protein identified as the 3C-like
proteinase, have been reported for mouse hepatitis virus
(Denison and Perlman, 1987; Denison et al., 1995; Lu et al.,
1995).
In this communication, we show that the IBV 3C-like
proteinase is involved in processing of the 1a polyprotein
to a 24-kDa mature viral product. By using a region-
specific antiserum (anti-24) raised in rabbits against the
IBV sequence encoded between nucleotides 10928 and
11493, the 24-kDa polypeptide was immunoprecipitated
from IBV-infected but not from mock-infected Vero cells.
Coexpression, deletion, and mutagenesis studies dem-
onstrated that this polypeptide was encoded by ORF 1a
between nucleotides 10915 and 11544 and was cleaved
from the 1a polyprotein by the 3C-like proteinase. Sub-
stitution mutation studies suggested that the predicted
Q3462S3463 dipeptide bond was responsible for the re-
lease of the N terminus, and the Q3672N3673 dipeptide
bond was responsible for the release of the C terminus
of the 24-kDa protein.
RESULTS AND DISCUSSION
Identification of a 24-kDa polypeptide in IBV-infected
Vero cells
We have previously shown that a novel ORF 1a-spe-
cific 10-kDa polypeptide encoded by ORF 1a from nucle-
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otide 11545 to 11877 was processed from the 1a polypro-
tein by the 3C-like proteinase (Liu et al., 1997). In an effort
to identify more viral polypeptides encoded by ORF 1a, a
region-specific antiserum, anti-24, was raised in rabbits
against a bacterially expressed protein containing the
IBV sequence encoded between nucleotides 10928 and
11493. This antiserum was then used to test if specific
viral products can be identified from IBV-infected Vero
cells. For this purpose, confluent monolayers of Vero
cells were infected with IBV at a multiplicity of infection
of approximately 2 PFU per cell. The cells were labeled
with [35S]methionine at 6 or 14 h postinfection and were
harvested 4 h after labeling. Cell lysates were prepared
and immunoprecipitated with anti-IBV, anti-24, and anti-
serum V47. Antiserum V47 was raised against the IBV
sequence encoded between nucleotides 11488 and
12600 and was used successfully in the identification of
a 10-kDa protein in IBV-infected cells (Liu et al., 1997).
Figure 1 shows the results of this experiment using
lysate prepared from Vero cells harvested at 10 h postin-
fection. As can be seen, a protein with an apparent
molecular weight of approximately 24 kDa was specifi-
cally precipitated with anti-24 antiserum from IBV-in-
fected, but not from mock-infected Vero cell lysates (Fig.
1). Immunoprecipitation of the same cell lysate with an-
tiserum V47, once again, led to the detection of the
10-kDa protein (Fig. 1) (also see Liu et al., 1997). No
obvious difference in abundance of the 24-kDa protein
was observed from lysates prepared from cells har-
vested at 10 and 18 h postinfection (data not shown).
Release of the 24-kDa protein from the 1a polyprotein
by the 3C-like proteinase
The detection of the 24-kDa protein in IBV-infected
Vero cells with a region-specific antiserum indicates that
it may be encoded by the corresponding region of ORF
1a. This possibility was investigated by coexpression of
plasmid pBP5 (Fig. 2a) in Vero cells with pIBV3C, a
plasmid containing the IBV sequence coding for the
3C-like proteinase (Liu et al., 1997). The cells were la-
beled with [35S]methionine for 4 h at 14 h posttransfec-
tion, and the expression of IBV-specific products was
analyzed by immunoprecipitation with anti-24 and anti-
serum V47. As shown in Fig. 2b, transfection of pBP5,
once again, showed the expression of the 60-kDa 1a
termination and the 72-kDa 1a/1b fusion products (see
also Liu et al., 1997); both products can be efficiently
precipitated by anti-24 and antiserum V47. Coexpression
of pBP5 with pIBV3C resulted in the detection of the
10-kDa protein and a product with an apparent molecular
weight of approximately 24 kDa; the 10- and 24-kDa
products were specifically immunoprecipitated by
anti-24 and antiserum V47, respectively (Fig. 2b). In ad-
dition, three more products with apparent molecular
masses of 55, 42, and 38 kDa were immunoprecipitated
by both antisera (Fig. 2b). They may represent interme-
diate processing products (see Fig. 2a); the identity of
these products was explored in the following sections.
To verify if the 24-kDa protein identified from coexpres-
sion of pBP5 and pIBV3C is the same product detected in
IBV-infected cells, Vero cell lysates prepared from IBV-
infected and plasmid-transfected cells were immunopre-
cipitated with anti-24 antiserum and the viral products
were analyzed by SDS–PAGE. The results obtained are
shown in Fig. 2c. As can be seen, comigration of the
24-kDa protein species was clearly observed, suggest-
ing that they are the same product.
The 24-kDa protein is a mature cleavage product
of the 1a polyprotein
As shown in Figs. 2b and 2c, coexpression of pBP5
with pIBV3C led to the detection of five cleavage prod-
ucts of 10, 24, 38, 42, and 55 kDa by immunoprecipitation
with anti-24 and antiserum V47. Since both the 10- and
24-kDa proteins were detected in IBV-infected cells and
the 10-kDa protein was a mature viral product, it was of
FIG. 1. Detection of a 24-kDa protein in IBV-infected Vero cells.
IBV-infected (I) and mock-infected (M) Vero cell monolayers in 35-mm
dishes were labeled with [35S]methionine for 4 h at 6 h postinfection.
Cell lysates were prepared by adding 1 ml of RIPA buffer to each dish.
The lysates were either analyzed (1.5 ml) directly or immunoprecipitated
(200 ml) with anti-IBV, anti-24, and antiserum V47. Polypeptides were
separated on an SDS–15% polyacrylamide gel and detected by fluorog-
raphy. Lanes labeled HMW, total ‘‘I’’, total ‘‘M’’, ‘‘I’’1anti-IBV, and
‘‘M’’1anti-IBV were exposed for 1 day, and the other lanes were ex-
posed for 14 days. HMW, high-molecular-weight protein markers (num-
bers indicate kilodaltons).
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interest to know if the 24-kDa protein was also a mature
cleavage product. For this purpose, Vero cells were co-
transfected with pBP5 and pIBV3C, but were labeled with
[35S]methionine for 13 h at 6 h posttransfection and were
chased with 10-fold excess of cold methionine up to 9 h.
As shown in Figs. 3a and 3b, after prolonged labeling,
only the 24- and 10-kDa proteins were detected by im-
munoprecipitation with anti-24 and antiserum V47, re-
spectively. This is consistent with our previous observa-
tion that only the 10-kDa protein was detectable by
FIG. 2. (a) Diagram showing the IBV sequence present in plasmid pBP5, the locations of four cleavage sites and the sequences used to raise anti-24
and antiserum V47. Also shown are the cleavage products encoded by this region of the IBV genome. The first nucleotide position of the IBV
sequences encoding the four cleavage products and the UGA termination codon for ORF 1a encoded by nucleotides 12382 to 12384 are also
indicated. (b) Analysis of transiently expressed mRNA 1 products from cotransfection of plasmids pBP5 and pIBV3C. Plasmid DNAs were expressed
in Vero cells using the vaccinia virus-T7 expression system described in Fuerst et al. (1986). Fifty to eighty percent confluent monolayers of Vero cells
in 35-mm dishes were infected with a recombinant vaccinia virus (vTF7-3) and were transfected with plasmid DNA using DOSPER according to the
instructions of the manufacturer (Boehringer Mannheim). Cells were labeled with [35S]methionine for 4 h at 14 h posttransfection and total cell lysates
were prepared by adding 500 ml of RIPA buffer to each dish. Two hundred microliters of the lysates was immunoprecipitated with antiserum V47 and
anti-24. Polypeptides were separated on an SDS–16% polyacrylamide gel and detected by fluorography. Numbers indicate molecular masses in
kilodaltons. (c) Comigration of the 24-kDa protein detected from IBV-infected (I) and plasmids (pBP5 and pIBV3C)-cotransfected Vero cells in
SDS–PAGE. Cell lysates were prepared as indicated in the legends for Fig. 1 and b and the same amount of lysate was immunoprecipitated with
anti-24. Viral polypeptides were separated on an SDS–16% polyacrylamide gel and detected by fluorography. Numbers indicate molecular masses
in kilodaltons.
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antiserum V47 from coexpression of pBP5 and pIBV3C
(Liu et al., 1997). The amount of both products remained
constant after chase for 9 h (Figs. 3a and 3b). These
results suggest that, like the 10-kDa polypeptide, the
24-kDa protein is also a mature product. The 38-, 42-, and
55-kDa proteins shown in Figs. 2b and 2c are therefore
intermediate cleavage products.
Mutational analysis of the N- and C-terminal cleavage
sites of the 24-kDa protein
Mutagenesis studies were then carried out to define
the N- and C-terminal cleavage sites of the 24-kDa pro-
tein. As anti-24 antiserum was raised against the IBV
sequence immediately upstream of the 10-kDa protein, it
is likely that the N-terminal cleavage site (the Q3672N3673
dipeptide bond) of the 10-kDa protein may be the C-
terminal cleavage site of the 24-kDa protein. Based on
the calculated molecular mass of the 24-kDa protein, a
previously predicted QS (Q3462S3463) dipeptide bond en-
coded by ORF 1a from nucleotide 10912 to 10917 may
therefore be the N-terminal cleavage site of the 24-kDa
protein (Gorbalenya et al., 1989). To test these possibil-
ities, plasmids containing substitution mutation of the Q
residue of the two putative scissile bonds to an E were
constructed and expressed in Vero cells using the vac-
cinia/T7 expression system (Fig. 4a).
The putative N-terminal QS (Q3462S3463 dipeptide
bond) cleavage site was first analyzed by this approach.
Plasmid pBP5Q3462-E, which covers the IBV sequence
from nucleotide 10752 to 11877 and contains the Q3462 to
E mutation, was constructed and expressed. As can be
seen, expression of pBP5Q3462-E alone resulted in the
detection of a protein of approximately 42 kDa (Fig. 4b),
representing the full-length product of this construct.
Interestingly, this product comigrated in sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
with the 42-kDa intermediate processing product de-
tected from coexpression of pBP5 and pIBV3C, indicating
FIG. 3. Pulse–chase analysis of the expression, processing, and accumulation of the 24 (a) and 10 (b) kDa proteins from cotransfection of pBP5
and pIBV3C. Fifty to eighty percent confluent monolayers of Vero cells in 35-mm dishes were infected with a recombinant vaccinia virus (vTF7-3) and
were transfected with plasmid DNA using DOSPER. Cells were labeled with [35S]methionine for 13 h at 6 h posttransfection and were chased with
10-fold excess of cold methionine for 0, 5, and 9 h as indicated above each lane. Cell lysates were prepared by adding 500 ml of RIPA buffer to each
dish and were either analyzed (1.5 ml) directly or immunoprecipitated (200 ml) with anti-24 (a) and antiserum V47 (b). Polypeptides were separated
on SDS–16% polyacrylamide gels and detected by fluorography. HMW, high-molecular-weight protein markers (numbers indicate kilodaltons).
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that they may encode by the same region of ORF1a (Fig.
4b). Coexpression of pBP5Q3462-E with pIBV3C, however,
led to the detection of the 10-kDa protein and a 28-kDa
novel product (Fig. 4b). The efficient immunoprecipitation
of the 28-kDa product with anti-24 antiserum indicates
that it may be a fusion protein containing the 24-kDa
protein and the upstream sequence (see Fig. 2a). These
results demonstrate that mutation of the Q3462S3463 to ES
blocks cleavage occurring at this position.
Similarly, substitution mutation of the Q3672N3673
dipeptide bond was carried out to test if it is indeed the
C-terminal cleavage site of the 24-kDa protein (Fig. 4a).
As can be seen, expression of plasmid pBP5Q3672-E led
to the synthesis of the full-length 42-kDa protein (Fig. 4c).
FIG. 4. (a) Diagram of the structures of plasmids pBP5Q3462-E and pBP5Q3672-E, showing the locations of the cleavage sites and the substitution
mutations introduced. The predicted protein species recognized by antiserum V47 and anti-24 are also shown. (b) Mutational analysis of the
N-terminal predicted cleavage site (Q3462-S3463) of the 24-kDa protein. Plasmid pBP5Q3462-E was coexpressed with pIBV3C in Vero cells using the
vaccinia virus-T7 expression system. Cells were labeled with [35S]methionine and total cell lysates were either analyzed directly or immunoprecipi-
tated with antiserum V47 and anti-24. Polypeptides were separated on an SDS–16% polyacrylamide gel and detected by fluorography. Numbers
indicate molecular masses in kilodaltons. (c) Mutational analysis of the C-terminal predicted cleavage site (Q3672-N3673) of the 24-kDa protein.
Numbers indicate molecular masses in kilodaltons.
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Coexpression of pBP5Q3672-E with pIBV3C resulted in
the detection of a novel product with an apparent mo-
lecular weight of approximately 38 kDa; neither the 24-
nor the 10-kDa product was generated from the coex-
pression of these two constructs (Fig. 4c). The 38-kDa
protein can be efficiently precipitated with both anti-24
and antiserum V47, suggesting that it may represent a
fusion product containing the 24- and 10-kDa proteins
(see Figs. 2a and 4a). We have noted that the apparent
molecular weight of 38 kDa of the fusion protein is
slightly larger than its calculated molecular weight of 35
kDa. This discrepancy may be due to some minor con-
formational changes of the fusion protein. Nevertheless,
these results demonstrate that a substitution mutation of
the Q3672N3673 dipeptide bond to EN abolishes cleavage
occurring at this position and suggest that the Q3672N3673
dipeptide bond is the C-terminal cleavage site of the
24-kDa protein. The 24-kDa protein is therefore encoded
within the IBV sequence from nucleotide 10915 to 11544.
The relative amount of the 24- and 10-kDa proteins
presented in antoradiographs shown in Figs. 1, 2a, and 3
was then analyzed by scanning densitometry (data not
shown). Taking account of the relative immunoprecipita-
tion efficiency of the two antisera against their common
targets and the methionine content of the two products
(the 24-kDa protein contains 4 and the 10-kDa protein
contains 3), it was noted that a very similar amount of the
24- and 10-kDa proteins was detected in IBV-infected as
well as plasmid DNA-transfected cells. As the two prod-
ucts were processed from the same precursors and no
intermediate cleavage product was detected with either
antiserum, it is reasonable to assume that, at least at
early stages of the IBV infection cycle, these two proteins
are produced and accumulated at very similar rates.
In addition to the 38- and 42-kDa intermediate cleav-
age products, coexpression of pBP5 with pIBV3C also
led to the detection of an intermediate cleavage product
of 55 kDa (Figs. 2b and 2c). From its apparent molecular
weight of 55 kDa, this product may be a fusion protein
covering both the 24- and the 10-kDa proteins as well as
a putative downstream cleavage product of 17 kDa (see
Fig. 2a). As this putative product was flanked by two
confirmed cleavage sites of the 3C-like proteins, i.e., the
C terminal cleavage site (Q3783S3784) of the 10-kDa pro-
tein and the N-terminal cleavage site (Q3928S3929) of the
100-kDa protein (see Fig. 2a), and no other potential
cleavage site was found to be located between these
two sites, it is unlikely that further cleavage may occur in
this region. To support this, we have reported that coex-
pression of pIBV3C with pBP5D4Q3783-E, which covers
the IBV sequence from nucleotide 11568 to 12312 and
contains a mutation of the Q3783S3784 to ES, resulted in
the detection of only the full-length product and trace
amount of cleavage product derived from cleavage at the
Q3783S3784 site (Liu et al., 1997). No other cleavage prod-
uct was detected (Liu et al., 1997), suggesting that this
putative 17-kDa protein may represent a mature cleav-
age product of the 1a polyprotein. Attempts have been
made to raise antiserum against this region, but no
success has been achieved so far. We are currently
unclear if this is due to the low antigenicity of the product
encoded by this particular region.
The identification of a 24-kDa product reported here
adds a new member to the growing list of nonstructural
products processed from the 741-kDa 1a/1b fusion
polyprotein encoded by IBV mRNA1. These include an
87-kDa protein encoded by the first 2.6-kb region of
ORF1a and a 10- and a 100-kDa protein encoded by the
IBV sequences from nucleotide 11545 to 11877 and 12313
to 15131, respectively (Liu et al., 1994, 1995, 1997; Liu and
Brown, 1995). The 100-kDa protein may be the viral poly-
merase as a putative RNA-dependent RNA polymerase
domain was identified in the region coding for this pro-
tein (Gorbalenya et al., 1989). So far, no functional roles
have been assigned to the 87-, 24-, and 10-kDa protein
species. As systems for molecular genetic analysis of
the IBV replication machinery are not yet available, it is
still difficult to determine the functions of these products
in the virus life cycle. However, analysis of their amino
acid sequences by computer-aided programs showed
that the 24- and 10-kDa proteins may contain hydropho-
bic/transmembrane domains (data not shown), indicat-
ing that they may be hydrophobic proteins. Small hydro-
phobic viral proteins are usually associated with host
cell membranes. This membrane-association property
may play an important role in viral RNA replication, as it
could act as anchorage of replication complexes. For
example, a 6-kDa viral protein from tobacco etch virus
was recently shown to be an integral membrane protein
associated with large vesicular compartments derived
from the endoplasmic reticulum of the host cells (Schaad
et al., 1997). This interaction is proposed to be essential
for targeting of the viral RNA replication complexes to
membranous sites of replication. Small hydrophobic viral
proteins, such as the enterovirus 2B protein, have also
been shown to be able to increase membrane perme-
ability of the host cells, causing membrane lesions and
facilitating release of the virus progeny (van Kuppeveld et
al., 1997). It is currently unclear if similar functions may
be played by the 24- and 10-kDa proteins during the IBV
replication cycle.
Mutagenesis studies presented in this communication
suggested that the Q3462S3463 and Q3672N3673 dipeptide
bonds were the N- and C-terminal cleavage sites of the
24-kDa protein, respectively. Examination of the amino
acid sequences shows that both cleavage sites have a
Leu residue at the P2 position. From the results shown in
Figs. 3b and 3c, it was also noted that a QA (Q3575A3576)
dipeptide bond encoded by the IBV sequence from nu-
cleotide 11251 to 11256 could not be recognized and
cleaved by the 3C-like proteinase. The amino acid resi-
due at the P2 position of this dipeptide bond is an Asp.
These observations are consistent with our working hy-
pothesis that the consensus amino acid sequence of the
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IBV 3C-like proteinase-dependent cleavage sites at P2-
P1-P19 positions may be L(V)-Q-S(GNA). Identification
and mutational analysis of more cleavage sites are un-
derway to generalize this conclusion.
MATERIALS AND METHODS
Virus and cells
The egg-adapted Beaudette strain of IBV (ATCC VR-22)
was obtained from the American Type Culture Collection
(ATCC) and was adapted to Vero cells as described by
Alonso-Caplen et al. (1984). Briefly, the virus was pas-
saged three times in 11-day-old chicken embryos and
then adapted to Vero cells (ATCC CCL-81) by a series of
passages at 24- to 48-h intervals. The cytopathic effects,
including syncytium formation and rounding up of cells,
were initially observed after three passages in Vero cells.
Virus stocks were prepared after the 34th passage by
infecting monolayers of Vero cells at a multiplicity of
infection of approximately 0.1 PFU/cell. The virus was
harvested at 24 h postinfection and the titer of the virus
preparation was determined by plaque assay on Vero
cells.
Vero cells were grown at 37°C in 5% CO2 and main-
tained in Glasgow’s modified minimal essential medium
supplemented with 10% newborn calf serum.
Labeling of IBV-infected cells with [35S]methionine
Confluent monolayers of Vero cells were infected with
IBV at a multiplicity of infection of approximately 2 PFU/
cell. Prior to being labeled, the cells were incubated in
methionine-free medium for 30 min. After 4 h of labeling
with [35S]methionine, the cells were scraped off the
dishes in phosphate-buffered saline, recovered by cen-
trifugation, and stored at 280°C.
Transient expression of IBV sequences in Vero cells
by using a vaccinia virus-T7 expression system
ORFs placed under the control of a T7 promoter were
expressed transiently in eukaryotic cells as described in
Fuerst et al., (1986). Semiconfluent monolayers of Vero
cells were infected with 10 PFU per cell of a recombinant
vaccinia virus (vTF7-3) which expresses the T7 phage
RNA polymerase and then transfected with appropriate
plasmid DNA by using DOSPER liposomal transfection
reagent according to the instructions of the manufacturer
(Boehringer Mannheim). After incubation of the cells at
37°C overnight (12 h), the cells were incubated in methi-
onine-free medium for 30 min prior to being labeled. After
4 h of labeling with [35S]methionine, the cells were lysed
with radioimmunoprecipitation assay buffer (RIPA) [50
mM Tris–HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.1%
SDS] and removed from the dishes. The lysates were
then precleared by centrifugation at 15,000 rpm for 5 min
at 4°C and stored at 280°C.
Radioimmunoprecipitation
Radioimmunoprecipitation with polyclonal rabbit anti-
sera was carried out as described previously (Liu et al.,
1991).
SDS–polyacrylamide gel electrophoresis
SDS–PAGE of viral polypeptides was carried out with
15 and 16% polyacrylamide concentrations (Laemmli,
1970). Labeled polypeptides were detected by autora-
diography or fluorography of dried gels.
Polymerase chain reaction (PCR)
Appropriate primers and template DNAs were used in
amplification reactions with PFU DNA polymerase (Strat-
agene) under standard buffer conditions with 2 mM
MgCl2.
Site-directed mutagenesis
Site-directed mutagenesis was carried out by two
rounds of PCR with two pairs of primers as described
(Liu et al., 1997). The mutations introduced were verified
by automated nucleotide sequencing.
Construction of plasmids
Plasmids pIBV3C and pBP5, which cover the IBV se-
quences from nucleotide 8869 [this position was misla-
beled in Liu et al., (1997)] to 9786 and from 10752 to
12600, respectively, were described before (Liu et al.,
1997).
Plasmids pBP5Q3462-E and pBP5Q3672-E, covering the
IBV sequence from nucleotide 10752 to 11877 and con-
taining, respectively, the Gln3462 to Glu and Gln3672 to Glu
mutations, were created by two rounds of PCR with pBP5
as templates (Liu et al., 1997). The sequence of the
primer used to introduce the Gln3462 to Glu mutation is
59-CAACTGTATTAGAATCGGTTAC-39, and the sequence
of the primer used to introduce the Gln3672 to Glu muta-
tion is 59-GATGTTGTTTTGGAGAATAAT-39. The sequence
of the upstream primer used for the second round of PCR
is 59-TAATACGACTCACTATAGGG-39, which is corre-
sponding to the T7 promoter sequence; the sequence of
the downstream primer is 59-GCTCCAGGATCCTACTGT-
TAAGACAAC-39, which contains a region complementary
to the IBV sequence from nucleotide 11866 to 11877 and
a UAG termination codon immediately downstream of
the viral sequence. The two PCR fragments were then
digested with Bg1II (Bg1II cuts the PCR fragment be-
tween the viral and the T7 promoter sequences) and
cloned into Bg1II and EcoRV-digested pKTO (Liu et al.,
1994), giving rise to pBP5Q3462-E and pBP5Q3672-E, re-
spectively. The mutations introduced were confirmed by
automated nucleotide sequencing.
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